郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

期刊：British journal of pharmacology发表年份：2013作者：S Molinari; V Camarda; A Rizzi; G Marzola; S Salvadori; E Marzola; P Molinari; J McDonald; M C Ko; D G Lambert; G Calo'; R Guerrini
阅读更多 →

药效评价Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.

期刊：Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology发表年份：2013作者：Manolo Mugnaini; Laura Iavarone; Palmina Cavallini; Cristiana Griffante; Beatrice Oliosi; Chiara Savoia; John Beaver; Eugenii A Rabiner; Fabrizio Micheli; Christian Heidbreder; Anne Andorn; Emilio Merlo Pich; Massimo Bani
阅读更多 →

药效评价Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2013作者：Denis O Sviridov; Alexander M Andrianov; Ivan V Anishchenko; John A Stonik; Marcelo J A Amar; Scott Turner; Alan T Remaley
阅读更多 →

药效评价Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.

期刊：Journal of medicinal chemistry发表年份：2013作者：Henry I Mosberg; Larisa Yeomans; Aubrie A Harland; Aaron M Bender; Katarzyna Sobczyk-Kojiro; Jessica P Anand; Mary J Clark; Emily M Jutkiewicz; John R Traynor
阅读更多 →